Principal Investigators: Suman Laal, PhD
Stellar Diagnostics is an early-stage medical diagnostics company focused on developing a rapid point-of-care tuberculosis test to replace the current sputum test. The company aims to make significant contributions in the area of diagnostics by offering world-class products at affordable prices to developing countries. They’re developing a serological-based, TB diagnostic test that uses highly immunogenic peptides of known proteins of TB bacteria to elicit an antibody response at all active stages of its growth spectrum. Additionally, the company is positioned to be a quality and science-driven manufacturer of lateral flow assays for infectious and vector-borne diseases. Collaborating with international experts, the company is committed to introducing sensitive tests for vector and viral infections while ensuring they meet all requirements of sensitivity and specificity.